June 15, 2023 - June 20, 2023

Cell Point (India) IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Cell Point (India) IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	0	0	1	0
%	0.00	0.00	0.00	100.00	0.00

Cell Point (India) IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Avoid

Cell Point (India) IPO Review by Dilip Davda (Avoid)

[Dilip Davda] The company operates in a highly competitive and fragmented segment with many players around. The sudden boost in its bottom line for 9M-FY23 raised eyebrows and concern over sustainability going forward. Based on such super earnings, the issue appears greedily priced, while based on its track records, it appears exorbitantly priced. There is no harm in skipping this pricey issue. Read detail review...

Cell Point (India) IPO Peer Comparison

Cell Point (India) Limited peer comparison with similar listed entities. () (As on June 09, 2023)

Company Name	EPS (Rs)	NAV (per share) (Rs)	P/E (x)	RoNW (%)
Company Name	EPS Basic	NAV (per share) (Rs)	P/E (x)	RoNW (%)
Cell Point (India) Limited	14.47	117.45	6.91	12.32
Bhatia Communications & Retail (India) Ltd	0.42	3.69	44.82	11.40
Fone4 Communications (India) Ltd	1.71	8.87	3.32	8.50
Jay Jalaram Technologies Ltd	7.36	39.40	7.17	8.61

Notes:

Cell Point (India) Limited's information is based on March 31, 2022, restated financial statements; for Jay Jalaram Technologies Ltd, it is based on the information as available in the Annual reports for FY 2021-22 as filed NSE; for Bhatia Communications & Retail (India) Ltd and Fone4 Communications (India) Ltd is based on data as available on moneycontrol.com website.
P/E for Jay Jalaram Technologies Ltd computed by dividing the closing market price on March 16, 2023, on NSE by EPS.
P/E for Bhatia Communications & Retail (India) Ltd and Fone4 Communications (India) Ltd computed by dividing the closing market price on March 16, 2023, on BSE by EPS.

Cell Point (India) IPO Review by Members

Cell Point (India) IPO Reviews, analysis and views by popular members. Read Cell Point (India) Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Cell Point (India) IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	2	0	1	1
%	50.00	0.00	25.00	25.00

Member	Review
FincaseIPO	Neutral Many brokers are doing the fixed work so I don't think there is any risk involved into subscribing this IPO. June 14, 2023 12:39:11 PM
IPO LEADER IPO Mentor (800+ Posts, 400+ Likes)	Avoid Discount issue June 15, 2023 8:41:31 AM
Ipokingstar	Apply for Long Term at Cut-off Price I am very much bullish on sme segment and specifically on retail business that’s why And very much strong customers More than 100 stores And home delivery of phones in 3 hours I like this business June 11, 2023 8:18:05 AM
RajaBanks	Apply for Listing Gain at Cut-off Price GMP active, probably going to apply just for listing gains. June 13, 2023 12:16:36 PM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.